Home » Topics » BioWorld Science

BioWorld Science
RSS

Effective attenuation of renal fibrosis with a potent HIPK2 inhibitor

Nov. 10, 2021

Intarcia Therapeutics identifies new neuropeptide Y receptor agonists

Nov. 10, 2021

New HIF-2alpha inhibitors discovered at NiKang Therapeutics

Nov. 10, 2021

Novartis and collaborators describe new antiviral compounds

Nov. 10, 2021

Jiangsu Simcere Pharmaceutical presents new SERDs

Nov. 10, 2021

Beta2-integrins as potential targets for ANCA-mediated glomerulonephritis

Nov. 10, 2021

IL-33, a potential new therapeutic target for diabetic kidney disease

Nov. 10, 2021

NN-1213 lowers appetite and body weight in animal models of obesity

Nov. 10, 2021

Researchers identify markers of adrenomyeloneuropathy severity

Nov. 10, 2021

New mouse model allows investigation of EP3 receptor function in the kidney tubule

Nov. 10, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...